466 related articles for article (PubMed ID: 12917905)
1. Long acting beta-agonists versus theophylline for maintenance treatment of asthma.
Shah L; Wilson AJ; Gibson PG; Coughlan J
Cochrane Database Syst Rev; 2003; (3):CD001281. PubMed ID: 12917905
[TBL] [Abstract][Full Text] [Related]
2. Long acting beta-agonists versus theophylline for maintenance treatment of asthma.
Wilson AJ; Gibson PG; Coughlan J
Cochrane Database Syst Rev; 2000; (2):CD001281. PubMed ID: 10796631
[TBL] [Abstract][Full Text] [Related]
3. Long-acting beta2-agonists versus theophylline for maintenance treatment of asthma.
Tee AK; Koh MS; Gibson PG; Lasserson TJ; Wilson AJ; Irving LB
Cochrane Database Syst Rev; 2007 Jul; 2007(3):CD001281. PubMed ID: 17636663
[TBL] [Abstract][Full Text] [Related]
4. Inhaled long acting beta agonists for stable chronic asthma.
Walters EH; Walters JA; Gibson MD
Cochrane Database Syst Rev; 2003; (4):CD001385. PubMed ID: 14583933
[TBL] [Abstract][Full Text] [Related]
5. Long-acting beta2-agonists for chronic obstructive pulmonary disease.
Appleton S; Smith B; Veale A; Bara A
Cochrane Database Syst Rev; 2000; (2):CD001104. PubMed ID: 10796594
[TBL] [Abstract][Full Text] [Related]
6. Regular treatment with long acting beta agonists versus daily regular treatment with short acting beta agonists in adults and children with stable asthma.
Walters EH; Walters JA; Gibson PW
Cochrane Database Syst Rev; 2002; 2002(4):CD003901. PubMed ID: 12519616
[TBL] [Abstract][Full Text] [Related]
7. Long-acting beta2-agonists for chronic asthma in adults and children where background therapy contains varied or no inhaled corticosteroid.
Walters EH; Gibson PG; Lasserson TJ; Walters JA
Cochrane Database Syst Rev; 2007 Jan; 2007(1):CD001385. PubMed ID: 17253458
[TBL] [Abstract][Full Text] [Related]
8. Long-acting beta2-agonists versus placebo in addition to inhaled corticosteroids in children and adults with chronic asthma.
Ni Chroinin M; Greenstone IR; Danish A; Magdolinos H; Masse V; Zhang X; Ducharme FM
Cochrane Database Syst Rev; 2005 Oct; (4):CD005535. PubMed ID: 16235410
[TBL] [Abstract][Full Text] [Related]
9. Combined corticosteroid and longacting beta-agonist in one inhaler for chronic obstructive pulmonary disease.
Nannini L; Lasserson TJ; Poole P
Cochrane Database Syst Rev; 2003; (4):CD003794. PubMed ID: 14583994
[TBL] [Abstract][Full Text] [Related]
10. Safety of regular formoterol or salmeterol in adults with asthma: an overview of Cochrane reviews.
Cates CJ; Wieland LS; Oleszczuk M; Kew KM
Cochrane Database Syst Rev; 2014 Feb; 2014(2):CD010314. PubMed ID: 24504983
[TBL] [Abstract][Full Text] [Related]
11. Long-acting beta2-agonists versus anti-leukotrienes as add-on therapy to inhaled corticosteroids for chronic asthma.
Ducharme FM; Lasserson TJ; Cates CJ
Cochrane Database Syst Rev; 2006 Oct; (4):CD003137. PubMed ID: 17054161
[TBL] [Abstract][Full Text] [Related]
12. Combined corticosteroid and long acting beta-agonist in one inhaler for chronic obstructive pulmonary disease.
Nannini L; Cates CJ; Lasserson TJ; Poole P
Cochrane Database Syst Rev; 2004; (3):CD003794. PubMed ID: 15266502
[TBL] [Abstract][Full Text] [Related]
13. Long-acting beta2-agonists for chronic obstructive pulmonary disease patients with poorly reversible airflow limitation.
Appleton S; Poole P; Smith B; Veale A; Bara A
Cochrane Database Syst Rev; 2002; (3):CD001104. PubMed ID: 12137617
[TBL] [Abstract][Full Text] [Related]
14. Regular treatment with formoterol versus regular treatment with salmeterol for chronic asthma: serious adverse events.
Cates CJ; Lasserson TJ
Cochrane Database Syst Rev; 2009 Oct; (4):CD007695. PubMed ID: 19821436
[TBL] [Abstract][Full Text] [Related]
15. Addition of inhaled long-acting beta2-agonists to inhaled steroids as first line therapy for persistent asthma in steroid-naive adults.
Ni CM; Greenstone IR; Ducharme FM
Cochrane Database Syst Rev; 2005 Apr; (2):CD005307. PubMed ID: 15846751
[TBL] [Abstract][Full Text] [Related]
16. Long-acting beta2-agonists for poorly reversible chronic obstructive pulmonary disease.
Appleton S; Poole P; Smith B; Veale A; Lasserson TJ; Chan MM
Cochrane Database Syst Rev; 2006 Jul; (3):CD001104. PubMed ID: 16855959
[TBL] [Abstract][Full Text] [Related]
17. Nocturnal asthma uncontrolled by inhaled corticosteroids: theophylline or long-acting beta2 agonists?
Holimon TD; Chafin CC; Self TH
Drugs; 2001; 61(3):391-418. PubMed ID: 11293649
[TBL] [Abstract][Full Text] [Related]
18. Long-acting beta2-agonist in addition to tiotropium versus either tiotropium or long-acting beta2-agonist alone for chronic obstructive pulmonary disease.
Farne HA; Cates CJ
Cochrane Database Syst Rev; 2015 Oct; (10):CD008989. PubMed ID: 26490945
[TBL] [Abstract][Full Text] [Related]
19. Regular treatment with salmeterol and inhaled steroids for chronic asthma: serious adverse events.
Cates CJ; Lasserson TJ; Jaeschke R
Cochrane Database Syst Rev; 2009 Jul; (3):CD006922. PubMed ID: 19588410
[TBL] [Abstract][Full Text] [Related]
20. Ipratropium bromide versus long-acting beta-2 agonists for stable chronic obstructive pulmonary disease.
Appleton S; Jones T; Poole P; Pilotto L; Adams R; Lasserson TJ; Smith B; Muhammad J
Cochrane Database Syst Rev; 2006 Jul; 2006(3):CD006101. PubMed ID: 16856113
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
